Endoscopic Sleeve Gastroplasty for Obesity and Microbiota Randomized Trial (ESGORT)
An Open-label, Randomized, Controlled Clinical Trial on the Effects of Endoscopic Sleeve Gastroplasty on Weight, Metabolic Risk Factors, Quality of Life, Satiety, Gastrointestinal Motility and Gut Microbiota
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
This NA trial investigates Endoscopic Sleeve Gastroplasty and Gastric Hormones and is currently ongoing. Fondazione Policlinico Universitario Agostino Gemelli IRCCS leads this study, which shows 8 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Mar 2026 — Present [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2024 — Mar 2026 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Mar 2024 — Jul 2024 [monthly]
Recruiting NA
-
Mar 2021 — Mar 2024 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Jan 2021 — Mar 2021 [monthly]
Recruiting NA
-
Aug 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2020 — Aug 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
For direct contact, visit the study record on ClinicalTrials.gov .